Abstract:Radiation-induced xerostomia remains one of common side effects for radiotherapy (RT) of nasopharyngeal carcinoma (NPC) and severely affects the quality of life for the NPC patients. We aim to investigate the feasibility of predicting parotid glands secretory function based on the changes of apparent diffusion coefficient (ADC) map from diffusion weighted MRI (DWI) of bilateral parotid glands during RT for NPC patients and to analyze the correlations between the delivered radiation dose, volume reduction of parotid glands and the salivary secretary function. Seventy-five NPC patients treated with IMRT were enrolled in the study. DWI data were acquired on a 3.0T MRI system at pre-RT, the 5th and 15th fractions and immediately post-RT. The ADC maps were created in the ipsilateral (IP) and contralateral parotid gland (CP). Chewing stimulating tests were used to evaluate the saliva secretion. Pearson analysis was used to assess the correlation between ADC, delivered dose, volume reduction, and saliva secretion. Mean ADC increases and volume reductions in both parotid glands were observed during RT. These changes generally occurred in two stages. At the 5th fraction, with the average (± standard deviation) delivered doses of 5.11 ± 6.73Gy (IP) and 4.84±4.01Gy (CP), the average saliva secretions reduced from 2.35 ± 0.18g (pre-RT) to 2.25 ± 0.18g (5th fraction). During this first stage, the mean ADC increased significantly by 16.51 ± 14.82% (IP), 13.44 ± 10.87% (CP), while the volumes of parotid glands had minimal changes (IP: 23.42 ± 8.33cm3 vs 23.12 ± 8.11cm3, CP: 24.37 ± 9.13 cm3 vs 23.81 ± 9.07 cm3). The increased mean ADC had a positive correlation with the delivered dose (r1 = 0.57, r2 = 0.58) and negative correlation with the decreased saliva secretion (r1 = -0.57, r2 = -0.65). In the second stage (from the 5th fraction to post-RT), with the total mean delivered doses to the parotid glands of 27.64 ± 3.63 Gy (IP) and 26.13 ± 2.16 Gy (CP), the average saliva secretion decreased to 1.70 ± 0.14 g (15th fraction) and 1.34 ± 0.15 g (post-RT). The mean ADC increased by 40.38 ± 21.91% (IP), 40.06 ± 23.91% (CP) in this stage, while the volumes of parotid glands decreased by 41.20 ± 10.77% (IP), 39.18 ± 11.88% (CP). The radiation dose positively correlated to increased ADC, and negatively correlated to the volume reduction and decreased salivary secretion. During radiotherapy for NPC, the ADC values of parotid glands increase dramatically. The increase positively correlates to radiation dose, and negatively correlates to the volume reduction and salivary secretion decrease. The mean ADC increases at the 5th fraction even no volume change is observed, indicating that the ADC is more sensitive biomarker that may be used to predict xerostomia in an early stage during RT for NPC, leaving enough time to adapt the remaining treatment if necessary.

Magnetic Resonance Sialography for Investigating Major Salivary Gland Duct System after Intensity-Modulated Radiotherapy of Nasopharyngeal Carcinoma

Magnetic Resonance Sialography to Evaluate Radiation-Induced Xerostomia in Patients with Early-Stage Nasopharyngeal Carcinoma

Oncological Outcome of Patients with Salivary Gland Cancer Treated with Surgery and Postoperative Intensity-Modulated Radiotherapy: a Retrospective Study

Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation

Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia

Diffusion-weighted MRI of salivary glands with gustatory stimulation: Comparison before and after radiotherapy

Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy

Evaluation of Salivary Gland Radioactive Damage by Diffusion Deighted Dagnetic Desonance Imaging

[Primary Effect of Submandibular Salivary Gland Transfer in Preventing Radiation-Induced Xerostomia of Nasopharyngeal Carcinoma].

Assessment and Prediction of Salivary Gland Function After Head and Neck Radiotherapy: A Systematic Review

Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-Year outcomes.

Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma

Survey on Xerostomia after radiotherapy for the nasopharyngeal carcinoing patients

Oncological Safty Evaluation of Submandibular Salivary Gland Transfer Prevents Radiation-Induced Xerostomia in the Patients with Nasopharyngeal Carcinoma

Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study

The Impact of Submandibular Glands Protection on Xerostomia As Monitored by Diffusion-Weighted Imaging in Nasopharyngeal Carcinoma Patients.

Research Advance of Salivary Gland Radiation Injury and Functional Evaluation Methods

Protective effect of intensity-modulated radiation therapy on salivary gland function in nasopharyngeal carcinoma patients

Early Prediction of Parotid Glands Secretory Function Based on MRI-ADC Acquired During Radiotherapy for Nasopharyngeal Carcinoma: A Phase II Prospective Study

Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma: Virtual Touch Tissue Quantification of Submandibular Gland

Sparing Submandibular Gland to Alleviating Acute Xerostomia in Patients with Nasopharyngeal Carcinoma Treated with Helical Tomotherapy: Evaluation by Diffusion Kurtosis Imaging